U S Physical Therapy (USPH) FY2016 results: revenue $357 million, up 7.6% on the year
U S Physical Therapy Inc. (USPH) reported revenue of $357 million for fiscal 2016, the year ended 31 December 2016, up 7.6% on the year before. Net income was $21 million, down 0.3%, and diluted earnings per share $1.64. The figures are the company's own, from the 10-K it filed with the SEC on 18 March 2019.
Revenue
$357 million
+7.6% on the year
FY2009FY2016
Operating margin
13.9%
14.3% a year earlier
FY2009FY2016
Net income
$21 million
-0.3% on the year
FY2009FY2016
Diluted EPS
$1.64
-7.3% on the year
FY2009FY2016
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Revenue
357
331
305
+7.6%
Gross profit
82.0
78.4
76.2
+4.7%
Gross margin
23.0%
23.7%
25.0%
Selling, general and administrative
32.5
31.1
30.4
+4.5%
Operating income
49.5
47.3
45.8
+4.7%
Operating margin
13.9%
14.3%
15.0%
Interest expense
11.5
7.2
7.5
+58.6%
Pre-tax income
38.1
40.1
38.3
-5.0%
Income tax
11.9
13.6
13.0
-12.9%
Effective tax rate
31.1%
34.0%
34.0%
Net income
20.6
20.6
19.1
-0.3%
Net margin
5.8%
6.2%
6.3%
Diluted EPS
$1.64
$1.77
$1.57
-7.3%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Operating cash flow
51.0
37.5
45.2
+36.1%
Capital expenditure
8.3
6.3
5.2
+31.9%
Free cash flow
42.8
31.3
40.0
+36.9%
Free cash flow margin
12.0%
9.4%
13.1%
Cash from investing
-32.5
-26.1
-22.9
Cash from financing
-14.3
-9.9
-20.9
Depreciation and amortisation
8.8
8.0
6.7
+10.4%
Share-based compensation
5.0
4.5
3.4
+10.5%
Dividends paid
8.5
7.4
5.9
+14.2%
Dividend per share
$0.68
$0.60
$0.48
+13.3%
Diluted shares, weighted
12m
12m
12m
+0.9%
Balance sheet
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Shareholders' equity
188
171
146
+9.6%
Non-controlling interest
1.1
1.3
20.9
-9.0%
Redeemable equity
0.0
0.0
7.4
Debt
51.8
49.1
35.6
+5.5%
Other liabilities
111
82.3
34.3
+34.5%
Total liabilities and equity
351
304
245
+15.6%
Fixed assets
19.2
16.7
15.8
+15.1%
Goodwill
227
195
172
+16.1%
Intangible assets
38.1
30.3
24.9
+25.6%
Cash and equivalents
20.0
15.8
14.3
+27.1%
Receivables
38.8
36.2
32.9
+7.2%
Other assets
8.3
9.4
n/a
-11.9%
Total assets
351
304
245
+15.6%
10-K for the year ended 31 December 2016, filed 18 March 2019: the filing.